Clinical Trials Logo

Early Osteoarthritis clinical trials

View clinical trials related to Early Osteoarthritis.

Filter by:
  • None
  • Page 1

NCT ID: NCT04267510 Completed - Clinical trials for Early Osteoarthritis

Clinical and Molecular Aspects of Early Osteoarthritis

Start date: January 1, 2013
Phase:
Study type: Observational

The etiology of osteoarthritis is varied, ranging from multifactorial, environmental to monogenic. In individuals in whom osteoarthritis appears earlier than in the general population, it is called early osteoarthritis. To our knowledge, there are no large-scale genetic studies on people with early osteoarthritis. The investigators therefore sought to study the causes of monogenic osteoarthritis in people suffering from early non-syndromic osteoarthritis. Material and method From 2013 to 2019, experts in constitutional bone disease sent patients with non-syndromic early osteoarthritis for genetic analysis to our center of competence for constitutional bone diseases. The sequencing of a panel of genes was carried out by NGS.

NCT ID: NCT01747018 Completed - Clinical trials for Early Osteoarthritis

Platelet Rich Plasma Injection for Knee Pain

Start date: February 2011
Phase: Phase 1/Phase 2
Study type: Interventional

Platelet-rich plasma (PRP) has been used as an alternative to non-operative treatments for increasing the rate of cure in bone and soft-tissue regeneration, although there are very few clinical studies regarding the treatment of articular cartilage damage. Therefore, our study proposes non-surgical intervention for patients with articular cartilage damage and who are experiencing knee pain caused by this damage. This study was conducted as a single medical center. It was an uncontrolled, prospective clinical trial, and the study subjects included 44 patients who were suffering from early osteoarthritis and degenerative chondropathy; they were between 18 and 65 years of age and were included in the study irregardless their sex. PRP was injected twice intraarticulary within an interval of four weeks. The pain scores and functional scores were compared two months, four months, and six months following the second injection was completed, using the VAS, the Lysholm knee scale, and the Cincinnati knee rating system.